Long-Term Non-Congenital Cardiac and Renal Complications in Down Syndrome: A Study of 32,936 Patients
Children · 05.08.2023 · 10 (8) · 1351
DOI: 10.3390/children10081351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Children, online erschienen am 05.08.2023. Verfasst von Yu-Nan Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 402306, Taiwan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University Hospital, Chung Shan Medical University Hospital, Chung Shan Medical University.
Abstract (Originalsprache)
Background
Individuals with Down syndrome are at a higher risk of cardiac, renal, and other health issues due to a complex disease physiology. However, few data exist on long-term disease risks to guide prevention and care. We aimed to determine the 10-year incidence of cardiac, renal, and urinary tract complications in Down syndrome versus matched controls.
Methods
This retrospective cohort study utilized a large collaborative database. We identified 32,444 patients with Down syndrome and matched controls, excluding those with pre-follow-up target events. Covariates included demographics, lifestyle factors, and comorbidities. Outcomes were ischemic heart disease, hypertension, hypothyroidism, epilepsy, urinary tract infections and chronic kidney disease. We calculated unadjusted and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) using Cox regression and plotted Kaplan–Meier survival curves.
Findings
Over 10 years, Down syndrome patients showed a 3.7-fold higher ischemic heart disease risk (95% CI: 3.0–4.6) and a 1.6-fold higher hypertension risk (95% CI: 1.4–1.8) versus controls. Hypothyroidism (HR = 2.0; 95% CI: 1.7–2.4), epilepsy (HR = 4.5; 95% CI: 3.5–5.8), and urinary tract infection (HR = 3.9; 95% CI: 3.4–4.6) risks were also higher. Chronic kidney disease risk was 2.7-fold greater (95% CI: 2.1–3.5). Survival analysis confirmed a significantly higher incidence of all outcomes in Down syndrome (p < 0.0001).
Interpretation
This large study found major health challenges in Down syndrome, with risks 3- to 5-fold higher for chronic conditions versus matched controls over 10 years. Though survival remains high with proper care, focusing resources on the prevention and management of complications in this high-risk group can optimize well-being across the lifespan. Future research accounting for limitations here would provide definitive estimates of disease risk in Down syndrome to guide targeted health strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 402306, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung 402306, Taiwan.
- Center for Health Data Science, Chung Shan Medical University Hospital, Taichung 402306, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung 402306, Taiwan.
- Division of Genetics and Metabolism, Children's Hospital of China Medical University, Taichung 404327, Taiwan.
- School of Medicine, China Medical University, Taichung 404327, Taiwan.
ORCID-Profile: Yu-Nan Huang, Jing-Yang Huang, Chung-Hsing Wang, Pen-Hua Su
Förderung
- China Medical University Hospital
- Chung Shan Medical University Hospital
- Chung Shan Medical University
Zitieren
APA
Huang, Y. N., Huang, J. Y., Wang, C. H., & Su, P. H. (2023). Long-Term Non-Congenital Cardiac and Renal Complications in Down Syndrome: A Study of 32,936 Patients. Children, 10(8), 1351. https://doi.org/10.3390/children10081351
Vancouver
Huang YN, Huang JY, Wang CH, Su PH. Long-Term Non-Congenital Cardiac and Renal Complications in Down Syndrome: A Study of 32,936 Patients. Children. 2023;10(8):1351. doi:10.3390/children10081351
BibTeX
@article{Huang2023,
author = {Huang, Yu-Nan and Huang, Jing-Yang and Wang, Chung-Hsing and Su, Pen-Hua},
title = {Long-Term Non-Congenital Cardiac and Renal Complications in Down Syndrome: A Study of 32,936 Patients},
journal = {Children},
year = {2023},
volume = {10},
number = {8},
pages = {1351},
doi = {10.3390/children10081351}
}
EUVIMED